Search for Clinical Trial Results
Acute Myelomonocytic Leukemia - 190 Studies Found
Status | Study |
Completed |
Study Name: Decitabine, Vorinostat, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
Interventions: |
Active, not recruiting |
Study Name: Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers Condition:
|
Completed |
Study Name: Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases Condition:
|
Completed |
Study Name: Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia Condition:
|
Terminated |
Study Name: AML Therapy With Irradiated Allogeneic Cells Condition:
|
Recruiting |
Study Name: Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Condition:
|
Recruiting |
Study Name: Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy Condition:
|
Active, not recruiting |
Study Name: MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
|
Terminated |
Study Name: Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
|